These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 8943786
21. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. Labrie F, Diamond P, Cusan L, Gomez JL, Bélanger A, Candas B. J Clin Endocrinol Metab; 1997 Oct; 82(10):3498-505. PubMed ID: 9329392 [Abstract] [Full Text] [Related]
22. Side effects of ovarian hyperstimulation: hormonal and lipid profile changes. Tadmor OP, Kleinman Y, Barr I, Gal M, Brooks BA, Diamant YZ. Int J Fertil Menopausal Stud; 1994 Oct; 39(2):105-10. PubMed ID: 8012439 [Abstract] [Full Text] [Related]
23. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338 [Abstract] [Full Text] [Related]
24. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels. Lehtonen A. Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812 [Abstract] [Full Text] [Related]
25. Dehydroepiandrosterone replacement in women with adrenal insufficiency. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. N Engl J Med; 1999 Sep 30; 341(14):1013-20. PubMed ID: 10502590 [Abstract] [Full Text] [Related]
26. Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women. Sumino H, Ichikawa S, Yoshida A, Murakami M, Kanda T, Mizunuma H, Sakamaki T, Kurabayashi M. Int J Obes Relat Metab Disord; 2003 Sep 30; 27(9):1044-51. PubMed ID: 12917709 [Abstract] [Full Text] [Related]
27. The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey. Christopher-Hennings J, Kurzman ID, Haffa AL, Kemnitz JW, Macewen EG. In Vivo; 1995 Sep 30; 9(5):415-20. PubMed ID: 8900917 [Abstract] [Full Text] [Related]
28. Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women. Gómez-Santos C, Hernández-Morante JJ, Tébar FJ, Granero E, Garaulet M. Clin Endocrinol (Oxf); 2012 Oct 30; 77(4):548-54. PubMed ID: 22136516 [Abstract] [Full Text] [Related]
29. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. Mortola JF, Yen SS. J Clin Endocrinol Metab; 1990 Sep 30; 71(3):696-704. PubMed ID: 2144295 [Abstract] [Full Text] [Related]
30. Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profile in plasma of obese women. Gómez-Santos C, Larqué E, Granero E, Hernández-Morante JJ, Garaulet M. Steroids; 2011 Dec 11; 76(13):1425-32. PubMed ID: 21840329 [Abstract] [Full Text] [Related]
31. [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study]. Rabijewski M, Zgliczyński W. Endokrynol Pol; 2005 Dec 11; 56(6):904-10. PubMed ID: 16821209 [Abstract] [Full Text] [Related]
32. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR. Fertil Steril; 2003 Dec 11; 80(6):1495-501. PubMed ID: 14667889 [Abstract] [Full Text] [Related]
33. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. Villareal DT, Holloszy JO. JAMA; 2004 Nov 10; 292(18):2243-8. PubMed ID: 15536111 [Abstract] [Full Text] [Related]
34. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA. J Clin Endocrinol Metab; 2002 May 10; 87(5):2046-52. PubMed ID: 11994339 [Abstract] [Full Text] [Related]
35. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, Buster JE. Fertil Steril; 1998 Jul 10; 70(1):107-10. PubMed ID: 9660430 [Abstract] [Full Text] [Related]
36. Metabolic effects of combined cyproterone acetate and percutaneous 17 beta oestradiol after six and twelve months therapy in 61 patients. Vexiau P, Gueux B, Vexiau-Robert D, Fiet J, Laureaux C, Tabuteau F, Brerault JL, Mathieson J, Cathelineau G. Horm Metab Res; 1988 Dec 10; 20(12):765-9. PubMed ID: 2975629 [Abstract] [Full Text] [Related]
37. Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey. Haffa AL, MacEwen EG, Kurzman ID, Kemnitz JW. In Vivo; 1994 Dec 10; 8(6):993-7. PubMed ID: 7772752 [Abstract] [Full Text] [Related]
38. Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids. Jankowski CM, Gozansky WS, Van Pelt RE, Wolfe P, Schwartz RS, Kohrt WM. Clin Endocrinol (Oxf); 2011 Oct 10; 75(4):456-63. PubMed ID: 21521341 [Abstract] [Full Text] [Related]
39. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B. J Clin Endocrinol Metab; 2001 May 10; 86(5):1968-72. PubMed ID: 11344193 [Abstract] [Full Text] [Related]